Telomir Pharmaceuticals, Inc. (TELO)
NASDAQ: TELO · Real-Time Price · USD
0.9751
-0.0349 (-3.46%)
At close: Oct 23, 2026, 4:00 PM EDT
1.000
+0.025 (2.55%)
After-hours: Oct 23, 2026, 7:58 PM EDT
Telomir Pharmaceuticals Market Cap
Telomir Pharmaceuticals has a market cap or net worth of $71.79 million as of October 23, 2026. It is the 27,472nd most valuable company in the world and the 4,363rd biggest in the United States. Its market cap has increased by 53.76% in one year.
Market Cap
71.79M
Enterprise Value
66.75M
1-Year Change
53.76%
Global Rank
Country Rank
#4,363 United States
Category
ChartMarket Cap Chart
Since the IPO on February 9, 2024, Telomir Pharmaceuticals's market cap has decreased from $207.27M to $71.79M, a decrease of -65.37%. That is a compound annual growth rate of -32.44%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 23, 2026 | 71.79M | 56.99% |
| Dec 31, 2025 | 45.73M | -62.70% |
| Dec 31, 2024 | 122.58M | -40.86% |
| Feb 9, 2024 | 207.27M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Cellectis | 76.40M |
| ProMIS Neurosciences | 74.79M |
| Acrivon Therapeutics | 74.14M |
| OKYO Pharma | 73.47M |
| Cingulate | 72.42M |
| Neumora Therapeutics | 71.29M |
| Cardiff Oncology | 70.58M |
| Nutriband | 70.02M |